Logo image of CSH.DE

CENIT AG (CSH.DE) Stock Fundamental Analysis

Europe - FRA:CSH - DE0005407100 - Common Stock

7.58 EUR
-0.12 (-1.56%)
Last: 9/23/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CSH. CSH was compared to 107 industry peers in the Software industry. Both the profitability and financial health of CSH have multiple concerns. CSH has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CSH had negative earnings in the past year.
In the past year CSH had a positive cash flow from operations.
CSH had positive earnings in 4 of the past 5 years.
CSH had a positive operating cash flow in each of the past 5 years.
CSH.DE Yearly Net Income VS EBIT VS OCF VS FCFCSH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

1.2 Ratios

CSH's Return On Assets of -3.06% is on the low side compared to the rest of the industry. CSH is outperformed by 61.68% of its industry peers.
Looking at the Return On Equity, with a value of -13.18%, CSH is doing worse than 65.42% of the companies in the same industry.
The Return On Invested Capital of CSH (0.91%) is comparable to the rest of the industry.
CSH had an Average Return On Invested Capital over the past 3 years of 3.71%. This is significantly below the industry average of 12.55%.
Industry RankSector Rank
ROA -3.06%
ROE -13.18%
ROIC 0.91%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
CSH.DE Yearly ROA, ROE, ROICCSH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

With a Operating Margin value of 0.80%, CSH perfoms like the industry average, outperforming 48.60% of the companies in the same industry.
In the last couple of years the Operating Margin of CSH has declined.
CSH has a Gross Margin of 60.01%. This is in the lower half of the industry: CSH underperforms 61.68% of its industry peers.
In the last couple of years the Gross Margin of CSH has grown nicely.
Industry RankSector Rank
OM 0.8%
PM (TTM) N/A
GM 60.01%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
CSH.DE Yearly Profit, Operating, Gross MarginsCSH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CSH is destroying value.
CSH has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CSH has about the same amount of shares outstanding.
Compared to 1 year ago, CSH has a worse debt to assets ratio.
CSH.DE Yearly Shares OutstandingCSH.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
CSH.DE Yearly Total Debt VS Total AssetsCSH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.06 indicates that CSH is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.06, CSH is not doing good in the industry: 62.62% of the companies in the same industry are doing better.
The Debt to FCF ratio of CSH is 5.94, which is a neutral value as it means it would take CSH, 5.94 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.94, CSH is in line with its industry, outperforming 50.47% of the companies in the same industry.
A Debt/Equity ratio of 1.16 is on the high side and indicates that CSH has dependencies on debt financing.
The Debt to Equity ratio of CSH (1.16) is worse than 80.37% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 5.94
Altman-Z 2.06
ROIC/WACC0.13
WACC6.92%
CSH.DE Yearly LT Debt VS Equity VS FCFCSH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.3 Liquidity

CSH has a Current Ratio of 1.22. This is a normal value and indicates that CSH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of CSH (1.22) is comparable to the rest of the industry.
A Quick Ratio of 1.22 indicates that CSH should not have too much problems paying its short term obligations.
The Quick ratio of CSH (1.22) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
CSH.DE Yearly Current Assets VS Current LiabilitesCSH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

3

3. Growth

3.1 Past

The earnings per share for CSH have decreased strongly by -255.17% in the last year.
CSH shows a small growth in Revenue. In the last year, the Revenue has grown by 7.67%.
The Revenue has been growing slightly by 3.84% on average over the past years.
EPS 1Y (TTM)-255.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)7.67%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%6.94%

3.2 Future

CSH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 40.95% yearly.
The Revenue is expected to grow by 3.08% on average over the next years.
EPS Next Y-19.08%
EPS Next 2Y43.82%
EPS Next 3Y40.95%
EPS Next 5YN/A
Revenue Next Year3.75%
Revenue Next 2Y4.52%
Revenue Next 3Y4.71%
Revenue Next 5Y3.08%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CSH.DE Yearly Revenue VS EstimatesCSH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M 250M
CSH.DE Yearly EPS VS EstimatesCSH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CSH. In the last year negative earnings were reported.
CSH is valuated reasonably with a Price/Forward Earnings ratio of 9.55.
Based on the Price/Forward Earnings ratio, CSH is valued cheaper than 92.52% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CSH to the average of the S&P500 Index (22.87), we can say CSH is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 9.55
CSH.DE Price Earnings VS Forward Price EarningsCSH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

CSH's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CSH is cheaper than 88.78% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CSH is valued cheaper than 93.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.01
EV/EBITDA 7.17
CSH.DE Per share dataCSH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

CSH's earnings are expected to grow with 40.95% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.82%
EPS Next 3Y40.95%

6

5. Dividend

5.1 Amount

CSH has a Yearly Dividend Yield of 4.15%, which is a nice return.
CSH's Dividend Yield is rather good when compared to the industry average which is at 2.14. CSH pays more dividend than 97.20% of the companies in the same industry.
CSH's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 4.15%

5.2 History

The dividend of CSH decreases each year by -41.82%.
Dividend Growth(5Y)-41.82%
Div Incr Years0
Div Non Decr Years0
CSH.DE Yearly Dividends per shareCSH.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2022 2023 2024 0.2 0.4 0.6

5.3 Sustainability

DP0%
EPS Next 2Y43.82%
EPS Next 3Y40.95%
CSH.DE Yearly Income VS Free CF VS DividendCSH.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

CENIT AG

FRA:CSH (9/23/2025, 7:00:00 PM)

7.58

-0.12 (-1.56%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-01 2025-08-01/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners52.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap63.44M
Analysts88.89
Price Target14.32 (88.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.15%
Yearly Dividend0.04
Dividend Growth(5Y)-41.82%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.1%
PT rev (3m)-12.89%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-41.15%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.91%
Revenue NY rev (3m)-5.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.55
P/S 0.3
P/FCF 8.01
P/OCF 6.91
P/B 1.76
P/tB N/A
EV/EBITDA 7.17
EPS(TTM)-0.57
EYN/A
EPS(NY)0.79
Fwd EY10.47%
FCF(TTM)0.95
FCFY12.48%
OCF(TTM)1.1
OCFY14.46%
SpS25.29
BVpS4.3
TBVpS-2.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.06%
ROE -13.18%
ROCE 1.88%
ROIC 0.91%
ROICexc 1.19%
ROICexgc 8.41%
OM 0.8%
PM (TTM) N/A
GM 60.01%
FCFM 3.74%
ROA(3y)2.61%
ROA(5y)3.04%
ROE(3y)8.37%
ROE(5y)8.11%
ROIC(3y)3.71%
ROIC(5y)4.08%
ROICexc(3y)4.78%
ROICexc(5y)6.49%
ROICexgc(3y)14.59%
ROICexgc(5y)14.62%
ROCE(3y)8.58%
ROCE(5y)8.95%
ROICexcg growth 3Y-6.55%
ROICexcg growth 5Y-5.33%
ROICexc growth 3Y-30.45%
ROICexc growth 5Y-21.57%
OM growth 3Y-8.13%
OM growth 5Y-9.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.52%
GM growth 5Y3.41%
F-Score5
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF 5.94
Debt/EBITDA 3.3
Cap/Depr 11.44%
Cap/Sales 0.59%
Interest Coverage 0.51
Cash Conversion 72.43%
Profit Quality N/A
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.06
F-Score5
WACC6.92%
ROIC/WACC0.13
Cap/Depr(3y)19.26%
Cap/Depr(5y)16.81%
Cap/Sales(3y)0.76%
Cap/Sales(5y)0.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-255.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y-19.08%
EPS Next 2Y43.82%
EPS Next 3Y40.95%
EPS Next 5YN/A
Revenue 1Y (TTM)7.67%
Revenue growth 3Y12.38%
Revenue growth 5Y3.84%
Sales Q2Q%6.94%
Revenue Next Year3.75%
Revenue Next 2Y4.52%
Revenue Next 3Y4.71%
Revenue Next 5Y3.08%
EBIT growth 1Y-80.36%
EBIT growth 3Y3.24%
EBIT growth 5Y-5.88%
EBIT Next Year139.79%
EBIT Next 3Y51.43%
EBIT Next 5Y27.41%
FCF growth 1Y-24.31%
FCF growth 3Y5.1%
FCF growth 5Y-0.8%
OCF growth 1Y-26.67%
OCF growth 3Y7.86%
OCF growth 5Y-2.42%